Analyst firms · Raymond James · NGM
Raymond James NGM price target and rating history
NGM Biopharmaceuticals Inc. (NGM) · Health Care
Raymond James rates NGM Biopharmaceuticals Inc. (NGM) Mkt Perform with a $4 price target, as of its latest action on Mar 12, 2024. It has published 5 rating actions on NGM since August 2021, including 1 upgrade and 2 downgrades.
- Current rating
- Mkt Perform
- Price target
- $4
- Median target, all firms
- Too few
- Actions on NGM
- 5
Raymond James price target on NGM
Every Raymond James rating on NGM
- Mar 12, 2024
- Oct 18, 2022
- Nov 5, 2021
- Sep 13, 2021
- Aug 6, 2021
Questions about Raymond James and NGM
- What is Raymond James's price target for NGM?
- Raymond James's latest stated price target for NGM Biopharmaceuticals Inc. (NGM) is $4, from its action on Oct 18, 2022.
- What is Raymond James's rating on NGM?
- Raymond James rates NGM Mkt Perform, a neutral rating, as of Mar 12, 2024.
- When did Raymond James last change its view on NGM?
- On Mar 12, 2024, Raymond James downgrades to Mkt Perform from Outperform.
All Raymond James ratingsNGM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.